Skip To Main Content
Rhythma Kaul on Muck Rack

Rhythma Kaul

Verified
New Delhi
As seen in: Hindustan Times, MSN India, Hindustan Times Mumbai, Hindustan Times Pune, Flipboard, Mint, EIN News, ThePrint, BusinessMirror, Rome News-Tribune, Hindustan and
National Health Editor @httweets. Public health, medicine, research & the occasional pandemic. Past: @indiatoday, @JNU_IN. Kashmir. Kitaab. Koffee
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rhythma

Contact Rhythma, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

No new H1N1 strain in circulation, current vaccines effective: ICMR officials

|
By Rhythma Kaul Verified
| Hindustan Times Verified
The influenza A (H1N1) strain currently circulating in India is not new, and most reported cases are causing mild symptoms, scientists at the Indian Council of Medical Research (ICMR) said. No new H1N1 strain has been identified in India, ICMR officials said, adding that current influenza vaccines remain well matched to circulating strains.
Open in Who Shared Issue with article?

Govt bans fixed-dose combo drugs with chlorpheniramine, phenylephrine for under 4yrs

|
By Rhythma Kaul Verified
| Hindustan Times Verified
The Union ministry of health and family welfare on Saturday announced that it has banned Fixed Dose Combinations (FDCs) containing chlorpheniramine maleate and phenylephrine hydrochloride for use in children below four years of age.
Open in Who Shared Issue with article?

India’s pharma exports grew 6.8% in Q1 FY27: Pharmexcil

|
By Rhythma Kaul Verified
| Hindustan Times Verified
India’s pharmaceutical exports grew by 6.8% to USD 8.10 billion during April–June financial year (FY) 2026-27, compared with USD 7.58 billion in the corresponding period of the previous financial year, despite recent concerns that US tariffs might negatively impact India’s pharma exports. India’s pharma exports grew 6.8% to $8.1 billion in Q1 FY27 despite concerns over US tariffs, with vaccines and bulk drugs driving growth.
Open in Who Shared View Duplicates (71) Issue with article?
See all 1,894 articles